Increased IGF-1 bioactivity inhibits apoptosis, stimulates cell proliferation and sex steroid synthesis and inhibits sex-hormone binding globulin synthesis, all of which could be implicated in the development of endometrial and ovarian cancer (Kaaks et al, 2002; Lukanova and Kaaks, 2005). The gene discussed is IGF1; the disease is ovarian carcinoma.